medigraphic.com

2012, Number 3

<< Back Next >>

Rev Latinoam Psiquiatría 2012; 11 (3)

Estigma y apego al tratamiento psiquiátrico en los trastornos mentales severos y persistentes

Flores RS, Medina DR, Robles GR, Páez AF

Language: Spanish
References: 32
Page: 82-89
PDF size: 276.34 Kb.


ABSTRACT

Mental illness is one of the most stigmatized health conditions. The stigma attaches undesirable features to whoever bears it, discrediting him before the others eyes. Once a label of mentally ill is received, the patient often feels embarrassed of taking medication, which diminishes drug adherence (mean 70%). One hundred mexican patients with a two or more year lasting severe and persistent mental disease completed the mental illness perceived stigma scale and the drug attitude inventory (DAI); the correlation among these two was determined (p ‹0.05). Schizophrenia was the most frecuently found diagnosis (47%). The mean number of drugs each patient was receiving was 3.5; most had been hospitalized at least once. The mean stigma score was found to be 60.15; while the DAI showed a 5.4 mean drug adherence. There was a relationship between the scale scores of perceived stigma and DAI scores (r = -0370, p ‹0.01) that is, less attachment greater stigma. Key words: Stigma, severe and persistent mental illness, mental illness, therapeutic adherence.


REFERENCES

  1. Goffman I. Stigma, notes on the management of spoiled identity. Prentice Hall Englewood Cliffs, 1963.

  2. Fink P, Tasman A. Stigma and mental illness. Washington: American Psychiatric Press, 1992.

  3. Heathertone T, Kleck R, Hebl M, Hull J. The social psychology of stigma. New York: The Guilford Press, 2000.

  4. Hinshaw S. The mark of shame: stigma of mental illness and an agenda for change. New York: Oxford University Press, 1999.

  5. Escudero de Santacruz, Medina Santacruz. Un bosquejo de personas mayores con trastorno mental de larga duración. Rev Asoc Colomb Gerontol Geriatr 2008;22(2):1132-1138.

  6. Laviana-Cuetos M. La atención a las personas con esquizofrenia y otros trastornos mentales graves desde los servicios públicos: una atención integral e integrada en un modelo comunitario. Apuntes de Psicología 2006;24(1-3): 345-373.

  7. Parabiaghi A, Bonetto C, Ruggeri M, Lasalvia A, Leese M. Severe and persistent mental illness: a useful definition for prioritizing community-based mental health service interventions. Soc Psychiatry Psychiatr Epidemiol 2006; 41:457-463.

  8. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M. Definition and prevalence of severe and persistent mental illness. British Journal of Psychiatry 2000;177:149-155.

  9. Britten N. Psychiatry, stigma and resistance. British Medical Journal 1998;317 (7164):963-964.

  10. Diccionario de la Real Academia de la Lengua Española. 22ª ed. Madrid: 2001.

  11. Tacchi Mj, Scout J. Mejora de la adherencia terapéutica en la esquizofrenia y el trastorno bipolar. Wiley 2006.

  12. Haynes RB, Taylor DW, Sackett DI. Compliance in health care. Baltimore: John Hopkins University Press, 1979;1-18.

  13. Thieda P, Beard S, Richter A, Kane J. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatric Serv 2003;54(4):508-516.

  14. Knapp M, King D, Punger K, Lapuerta P. Non-adherence to antipsychotic medication regimens: Association with resourses use and costs. Br J Psychiatry 2004;184:509-516.

  15. Cramer Ja, Rosenheck R. Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis 1999;187:53-55.

  16. Löffler W, Kilian R, Toumi M, Angermeyer MC. Schizophrenic patients´ subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 2003;36(3):105-112.

  17. Perlick DA, Rosenheck RA, Kaczynski R, Kozma L. Medication non-adherence in bipolar disorder: a patient centered review of research findings. Clin Approaches Bipolar Disorders 2004;3:56-64.

  18. Sirey JOA, Bruce M, Alexopoulus G, Perlick D, Friedman S, Meyers B. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Services 2001;52:1615-1620.

  19. Sirey JO A, Bruce M, Alexopoulus G, Perlick D, Raue P, Friedman S, Meyers B. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 2001;158:479-481.

  20. Jamison KR, Akiskal HS. Medication compliance in patients with bipolar disorder. Psychiatr Clin North Am 1983;6:175-192.

  21. Scott J, Pope M. Non-adherence with mood stabilizers: prevalence and predictors. J Clin Psycol 2002;63:384-390.

  22. Interian A, Martinez I, Guarnaccia P, Vega W, Escobar J. A Qualitative Analysis of the Perception of Stigma among Latinos Receiving Antidepressants. Psychiatr Serv 2007;58(12):1591- 1594.

  23. Björkman T, Bengt S, Bertil L. Experiences of stigma among people with severe mental illness. Reliability, acceptability and construct validity of the Swedish versions of two stigma scales measuring devaluation/discrimination and rejection experiences. Nord J Psychiatry 2007;61(5):332-338.

  24. Organización Mundial de la Salud (OMS). Día mundial de la salud mental 2008.

  25. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004;161(4):692-699.

  26. Apiquián-Guitart R, Fresán A, García M, Lóyzaga C, Nicolini H. Impacto de la duración de la psicosis no tratada en pacientes con primer episodio psicótico. Estudio de seguimiento a un año. Gac Méd Méx 2006;142(2):113-120.

  27. Salazar M, Peralta C, Pastor J. Tratado de psicofarmacología; bases y aplicación clínica. México: Médica Panamericana, 2004:348-367.

  28. Wikinski S, Jufe G. El tratamiento farmacológico en psiquiatría; indicaciones, esquemas terapéuticos y elementos para su aplicación racional. México: Médica Panamericana, 2004.

  29. Flores S, Medina D, Robles R. Estudio de traducción al español y evaluación psicométrica de una escala para medir el estigma internalizado en pacientes con trastornos mentales graves. Salud Mental 2011;34(4):333-339.

  30. Robles R, Salazar V, Páez F, Barreto R. Evaluación de actitudes al medicamento en una muestra de pacientes con esquizofrenia, propiedades psicométricas de la versión en español del DAI. Actas Esp Psiquiatr 2004; 32(3):138-142.

  31. American Psychiatric Association. DSM-IVTR. Manual Diagnóstico y Estadístico de los Trastornos Mentales, 2000.

  32. Bobes J, Portilla G, Bascarán MT, Sáiz PA, Bousoño M. Banco de Instrumentos Básicos para la práctica de la Psiquiatría Clínica. 2ª ed. Madrid: Ars Médica.




2020     |     www.medigraphic.com